Charles H. Adler

Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

Jeffrey H. Kordower, C. Warren Olanow, Hemraj B. Dodiya et al. · Brain · 2013 · 1.3K citations · Full text

Disease Duration, Dopaminergic Markers, Dopamine Loss +22

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

Thomas G. Beach, Charles H. Adler, Lucia I. Sue et al. · Acta Neuropathologica · 2010 · 880 citations · Full text

Neurodegenerative Diseases, Multi-organ Distribution, Phosphorylated α-Synuclein Histopathology +6

MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI

Irene Litvan, Dag Aarsland, Charles H. Adler et al. · Movement Disorders · 2011 · 789 citations · Full text

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

Thomas G. Beach, Charles H. Adler, Lih‐Fen Lue et al. · Acta Neuropathologica · 2009 · 675 citations · Full text

Neuropsychology, Motor Dysfunction, Corticobasal Degeneration +11

Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease

Daniel Weintraub, Staci Hoops, Judy A. Shea et al. · Movement Disorders · 2009 · 520 citations · Full text

Neuropsychology, Behavioral Addiction, Impulsive‐compulsive Disorders +18